Position in ARGX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$345,127
+$78,587 QoQ
Shares Held
372
+1.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#339
of 504 holders
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Dorsey & Whitney Trust CO LLC holds $14,461,634 across 10 Biotechnology names. ARGX ranks #7 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
136,026 | $9,610,234 | |
| 2 | VKTX |
Viking Therapeutics, Inc.
|
29,871 | $1,165,267 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,284 | $1,134,527 | |
| 4 | VCEL |
Vericel Corp
|
13,049 | $580,549 | |
| 5 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
694 | $372,642 | |
| 6 | STOK |
Stoke Therapeutics, Inc.
|
10,816 | $353,898 | |
| 7 | ARGX |
Argenx SE
This page
|
372 | $345,127 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
1,787 | $334,668 |
All Filings in ARGX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $345,127 | 372 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $266,540 | 365 | Shares | Other | 2026-05-14 | |
| 2025-12-31 | $328,808 | 391 | Shares | Other | 2026-02-11 | |
| 2025-09-30 | $260,355 | 353 | Shares | Other | 2025-11-13 | |
| 2025-03-31 | $203,007 | 343 | Shares | Other | 2025-05-14 | |
| 2024-12-31 | $219,555 | 357 | Shares | Other | 2025-02-07 | |
| No filing history on record for this holder in this stock. | ||||||